Long‐ COVID in children and their parents: A prospective cohort study
Pediatrics International · 2025-01 · 67 (1)
DOI: 10.1111/ped.70042 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Pediatrics International, online erschienen am 12.05.2025. Verfasst von Hiroyuki Iijima und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Pediatrics and Interdisciplinary Medicine, National Center for Child Health and Development, Tokyo, Japan. Hauptthemen laut MEDLINE: COVID-19, Quality of Life, Parents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Society for the Promotion of Science.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Long‐COVID is a significant global health concern, regardless of age. However, few reports have longitudinally evaluated the characteristics, prevalence, and risk factors of long‐COVID in children.
Methods
Participants were Japanese children younger than 18 years hospitalized for COVID‐19 between November 2021 and October 2022, along with their COVID‐19 affected parents. During hospitalization and at 1‐, 3‐, and 6‐month follow‐ups, participants completed age‐appropriate questionnaires on long‐COVID symptoms. The quality of life (QOL) score was assessed in children older than 2 years. The prevalence of long‐COVID symptoms by age group was compared. Multivariable logistic regression analysis was conducted to investigate risk factors affecting long‐COVID. Analysis of covariance adjusted for potential confounders was conducted to determine which symptoms affect QOL score.
Results
Of 108 children enrolled, the prevalence of long‐COVID was 44.9%, 37.8%, and 22.8% at 1, 3, and 6 months, respectively, after SARS‐CoV‐2 infection. There were no specific risk factors for long‐COVID. Cough, fatigue, and sleep disturbance were the most common long‐COVID symptoms, with sleep disturbance associated with a change in lower QOL score from admission at all three follow‐ups (mean difference 9.25, 20.15, and 19.81; 95% CI, 1.58–16.91, 3.38–36.92, and 5.51–34.11). The prevalence of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) symptoms among 0–6 years was significantly lower than among 7–17 years and parents; there was no significant difference between 7 and 17 years and parents.
Conclusion
Even 6 months after SARS‐CoV‐2 infection, 22.8% of pediatric patients still had long‐COVID symptoms. Some of these symptoms were similar to those of ME/CFS, potentially affecting children's QOL.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of General Pediatrics and Interdisciplinary Medicine, National Center for Child Health and Development, Tokyo, Japan.
- Division of Infectious Diseases, Department of Medical Subspecialties, National Center for Child Health and Development, Tokyo, Japan.
ORCID-Profile: Hiroyuki Iijima, Takanori Funaki, Mitsuru Kubota
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Iijima, H., Funaki, T., & Kubota, M. (2025). Long‐ COVID in children and their parents: A prospective cohort study. Pediatrics International, 67(1). https://doi.org/10.1111/ped.70042
Vancouver
Iijima H, Funaki T, Kubota M. Long‐ COVID in children and their parents: A prospective cohort study. Pediatrics International. 2025;67(1). doi:10.1111/ped.70042
BibTeX
@article{Iijima2025,
author = {Iijima, Hiroyuki and Funaki, Takanori and Kubota, Mitsuru},
title = {Long‐ COVID in children and their parents: A prospective cohort study},
journal = {Pediatrics International},
year = {2025},
volume = {67},
number = {1},
doi = {10.1111/ped.70042}
}
EUVIMED